Healio24d
Mortality risk rises between ages 11 and 65 years in acute respiratory distress syndrome
The association between age and 90-day mortality in acute respiratory distress syndrome was nonlinear. The risk for death stayed elevated after a patient turned 65 years old but rose in a slower ...
HMPV vs Covid-19: Understanding the key differences and dangers
As India logs 5 cases of HMPV, here's all you need to know about how human metapneumovirus is different from Covid-19 and ...
Pharmaceutical Technology7d
CK-0802 by Cellenkos for Coronavirus Disease 2019 (COVID-19) Associated Acute Respiratory Distress Syndrome: Likelihood of Approval
CK-0802 is under clinical development by Cellenkos and currently in Phase I for Coronavirus Disease 2019 (COVID-19) Associated Acute Respiratory Distress Syndrome.
What to Know About Bird Flu in the U.S. After CDC Announces First ‘Severe’ Human Case
Here’s what to know about the United States’ first confirmed severe case of H5N1 avian influenza—and how to protect yourself.
Daily2d
Unveiling Impact of VV ECMO on COVID-19 Patients: Study evaluates Respiratory Rescue
The Extracorporeal Life Support Organization has documented the application of venovenous extracorporeal membrane oxygenation ...
HMPV virus outbreak: Everything you need to know about symptoms and prevention
Human Metapneumovirus (HMPV) is a contagious respiratory virus causing symptoms similar to RSV and the flu, posing ...
Pharmaceutical Technology13d
Ibudilast by MediciNova for Coronavirus Disease 2019 (COVID-19) Associated Acute Respiratory Distress Syndrome: Likelihood of Approval
Ibudilast is under clinical development by MediciNova and currently in Phase II for Coronavirus Disease 2019 (COVID-19) Associated Acute Respiratory Distress Syndrome.